Tom, I would love to be able to reach the same conclusion as you but I am struggling to do so. The one thing I am pretty clear about is that there is a very low probability, that on an net basis, Cogstate will be able to replace the US$ 15 million of healthcare revenue it is giving up in the same time frame. The only way they will be able to do it is with more than one significant partnerships.
I think in retrospect the departure of Brad's wife as the head of healthcare was probably a sign that things were not going to plan with Eisai and Cognigram.
CGS Price at posting:
$1.30 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)